Intraoperative maneuvers may affect the development of early postoperative small bowel obstruction after laparoscopic colorectal cancer surgery: Multicenter prospective cohort study.


Journal

International journal of surgery (London, England)
ISSN: 1743-9159
Titre abrégé: Int J Surg
Pays: United States
ID NLM: 101228232

Informations de publication

Date de publication:
Feb 2021
Historique:
received: 13 11 2020
revised: 06 01 2021
accepted: 17 01 2021
pubmed: 29 1 2021
medline: 12 5 2021
entrez: 28 1 2021
Statut: ppublish

Résumé

Early postoperative small bowel obstruction (EPSBO) is one of the most common complications after colorectal cancer (CRC) surgery, and clarification of its causes is desired. Several reports have demonstrated the risks of EPSBO, but few have focused on laparoscopic surgery for CRC and intraoperative maneuvers. We therefore prospectively examined the risk factors for EPSBO after laparoscopic CRC resection. We prospectively enrolled 706 patients with CRC that underwent laparoscopic CRC resection in our hospital and affiliated hospitals. We analyzed several factors concerning EPSBO including intraoperative procedures. EPSBO developed in 43 of the 706 cases (6.1%). Univariate analysis showed that risk factors for EPSBO were male sex, increased operative time, repositioning of the small intestine before wound closure and anastomotic leakage. Risk factors for EPSBO according to multivariate analysis were increased operative time (odds ratio (OR) 2.41; P = 0.032), repositioning of the small intestine before wound closure (OR 3.58; P = 0.005) and anastomotic leakage (OR 3.91; P = 0.006). To reduce EPSBO after laparoscopic CRC surgery, the operation should be finished as soon as possible without performing optional maneuvers. To avoid development to EPSBO, particular care is required in cases where the risk of anastomotic leakage is predicted to be high.

Sections du résumé

BACKGROUND BACKGROUND
Early postoperative small bowel obstruction (EPSBO) is one of the most common complications after colorectal cancer (CRC) surgery, and clarification of its causes is desired. Several reports have demonstrated the risks of EPSBO, but few have focused on laparoscopic surgery for CRC and intraoperative maneuvers. We therefore prospectively examined the risk factors for EPSBO after laparoscopic CRC resection.
METHODS METHODS
We prospectively enrolled 706 patients with CRC that underwent laparoscopic CRC resection in our hospital and affiliated hospitals. We analyzed several factors concerning EPSBO including intraoperative procedures.
RESULTS RESULTS
EPSBO developed in 43 of the 706 cases (6.1%). Univariate analysis showed that risk factors for EPSBO were male sex, increased operative time, repositioning of the small intestine before wound closure and anastomotic leakage. Risk factors for EPSBO according to multivariate analysis were increased operative time (odds ratio (OR) 2.41; P = 0.032), repositioning of the small intestine before wound closure (OR 3.58; P = 0.005) and anastomotic leakage (OR 3.91; P = 0.006).
CONCLUSION CONCLUSIONS
To reduce EPSBO after laparoscopic CRC surgery, the operation should be finished as soon as possible without performing optional maneuvers. To avoid development to EPSBO, particular care is required in cases where the risk of anastomotic leakage is predicted to be high.

Identifiants

pubmed: 33508470
pii: S1743-9191(21)00014-5
doi: 10.1016/j.ijsu.2021.01.007
pii:
doi:

Types de publication

Evaluation Study Journal Article Multicenter Study

Langues

eng

Sous-ensembles de citation

IM

Pagination

52-56

Commentaires et corrections

Type : CommentIn

Informations de copyright

Copyright © 2021 IJS Publishing Group Ltd. Published by Elsevier Ltd. All rights reserved.

Auteurs

Yuki Nakamura (Y)

Second Department of Surgery, School of Medicine, Wakayama Medical University, 811-1, Kimiidera, Wakayama, 641-8510, Japan.

Kenji Matsuda (K)

Second Department of Surgery, School of Medicine, Wakayama Medical University, 811-1, Kimiidera, Wakayama, 641-8510, Japan.

Shozo Yokoyama (S)

Second Department of Surgery, School of Medicine, Wakayama Medical University, 811-1, Kimiidera, Wakayama, 641-8510, Japan; Department of Surgery, National Hospital Organization Minami Wakayama Medical Center, 27-1, Takinaicho, Tanabe, Wakayama, 646-8558, Japan.

Tsukasa Hotta (T)

Second Department of Surgery, School of Medicine, Wakayama Medical University, 811-1, Kimiidera, Wakayama, 641-8510, Japan; Department of Surgery, Saiseikai Wakayama Hospital, 45, Jyunibancho, Wakayama, 640-8158, Japan.

Katsunari Takifuji (K)

Second Department of Surgery, School of Medicine, Wakayama Medical University, 811-1, Kimiidera, Wakayama, 641-8510, Japan; Department of Surgery, Saiseikai Arida Hospital, 52-6, Yoshikawa, Yuasacho, Arida, Wakayama, 643-0007, Japan.

Motoki Yamamoto (M)

Department of Surgery, Labour Health and Welfare Organization Wakayama Rosai Hospital, 93-1, Kinomoto, Wakayama, 640-8505, Japan.

Makoto Iwahashi (M)

Department of Surgery, Labour Health and Welfare Organization Wakayama Rosai Hospital, 93-1, Kinomoto, Wakayama, 640-8505, Japan.

Toshiji Tominaga (T)

Department of Surgery, National Hospital Organization Osaka Minami Medical Center, 2-1, Kidohigashimachi, Kawachinagano, Osaka, 586-8521, Japan.

Tetsuya Horiuchi (T)

Department of Surgery, National Hospital Organization Osaka Minami Medical Center, 2-1, Kidohigashimachi, Kawachinagano, Osaka, 586-8521, Japan.

Hiroyuki Kinoshita (H)

Department of Surgery, Naga Hospital, 1282, Uchita, Kinokawa, Wakayama, 649-6414, Japan.

Hideaki Tsubakihara (H)

Department of Surgery, Naga Hospital, 1282, Uchita, Kinokawa, Wakayama, 649-6414, Japan.

Kohei Noguchi (K)

Department of Surgery, Izumiotsu Municipal Hospital, 16-1, Gejocho, Izumiotsu, Osaka, 595-0027, Japan.

Kazuya Yamaguchi (K)

Department of Surgery, Hidaka Hospital, 116-2, Sono, Gobo, Wakayama, 644-0002, Japan.

Kosuke Shimada (K)

Department of Surgery, Hashimoto Municipal Hospital, 2-8-1, Ominedai, Hashimoto, Wakayama, 648-0005, Japan.

Yoshimasa Oku (Y)

Second Department of Surgery, School of Medicine, Wakayama Medical University, 811-1, Kimiidera, Wakayama, 641-8510, Japan.

Hiroki Yamaue (H)

Second Department of Surgery, School of Medicine, Wakayama Medical University, 811-1, Kimiidera, Wakayama, 641-8510, Japan. Electronic address: yamaue-h@wakayama-med.ac.jp.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH